Carmen García‐Ruiz

University of Southern California — United States

Medicine · Health Sciences

73h-index23.5kcitations249works3.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(81), Sphingolipid Metabolism and Signaling(38), Alcohol Consumption and Health Effects(33), Sulfur Compounds in Biology(31), Peroxisome Proliferator-Activated Receptors(25)

Publications246 total

Prenols and Prenoic Acids in Metabolism, Disease, and Aging
Preprints.org·2025· 1 citedOpen Access
<scp>l</scp> -Cysteine-Glutathione Mixed Disulfide, a Novel Bioavailable Sulfhydryl-Modified Glutathione Precursor, Protects against Early Liver Injury Induced by Short-Term Hypercholesterolemia
Chemical Research in Toxicology·2025· 1 citedOpen Access
Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation
Journal of Lipid Research·2025Open Access
Bile acids in liver and gastrointestinal cancer
Seminars in Cancer Biology·2025· 4 citedOpen Access
900 - VIOLENCIA SEXUAL FACILITADA POR DROGAS EN CONTEXTOS DE FIESTA JUVENIL: COMUNICACIÓN DEL SUCESO
Gaceta Sanitaria·2025Open Access
Abstract 1592 Hepatic Mitochondrial-Derived Oxysterols Link Mash to Cardiovascular Disease
Journal of Biological Chemistry·2025Open Access
Abstract 1593 Expression Of SREBF2 And HMGCR Discriminate the Viability of Steatotic Grafts for Human Liver Transplantation and Contribute to its Outcome
Journal of Biological Chemistry·2025Open Access
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis
Acta Neuropathologica Communications·2025· 1 citedOpen Access
DATASET - Gender perspectives in STEM education.
2025Open Access
Stard1 promotes cholestatic liver injury and disease progression by sensitizing to bile acid hepatotoxicity
Hepatology·2024· 3 cited
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Exploration of Digestive Diseases·2024· 9 citedOpen Access
Cholesterol’s new tricks propel MASH-HCC: impact in immunotherapy
Gut·2024· 1 citedOpen Access
Palmitoylcarnitine impairs immunity in decompensated cirrhosis
JHEP Reports·2024· 6 citedOpen Access
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis
Molecular Metabolism·2024· 19 citedOpen Access
S-Adenosyl-l-methionine restores brain mitochondrial membrane fluidity and GSH content improving Niemann-Pick type C disease
Redox Biology·2024· 8 citedOpen Access
Elevated cholesterol in <i>ATAD3</i> mutants is a compensatory mechanism that leads to membrane cholesterol aggregation
Brain·2024· 7 citedOpen Access
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Pharmacological Research·2023· 4 citedOpen Access
Zonal expression of StARD1 and oxidative stress in alcoholic-related liver disease
Journal of Lipid Research·2023· 10 citedOpen Access
Tcf20 deficiency is associated with increased liver fibrogenesis and alterations in mitochondrial metabolism in mice and humans
Liver International·2023· 6 citedOpen Access
HILPDA, a new player in NASH-driven HCC, links hypoxia signaling with ceramide synthesis
Journal of Hepatology·2023· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

José C. Fernández‐Checa(46), Albert Morales(25), Anna Colell(25), Montserrat Marı́(20), Neil Kaplowitz(16), Ana María Cameán Fernández(7), Sandra Torres(7), Anna Baulies(7), Carlos Enrich(5), Vicent Ribas(5), Raquel Fucho(5), Merce Miranda(4), Esther Ardite(4), Josep M. Lluis(4), Laura Martínez-Gili(4), Montserrat Elena(4), Joan Caballería(4), Joan Montero(3), Laura Llacuna(3), Gorka Basáñez(3)